A personalized, integrated approach to oncology development that is disrupting traditional methods
A personalized, integrated approach to oncology development that is disrupting traditional methods
Oncology Site Network for predictable start-up and performance
Over the 20+ years we’ve been running oncology clinical trials, we’ve developed a network of 70+ global centers of excellence, the Precision Oncology Site Network (OSN), for oncology and immuno-oncology studies. The OSN includes many of the world’s leading cancer research organizations, and our ongoing relationship with these sites translates into rapid study start-up (as little as 90 days for some sites), highly efficient operations, and dependable organizational quality.
Oncology Site Network for predictable start-up and performance
77 global centers of excellence
These are just a few of our OSN sites:
- City of Hope
- Mary Crowley
- Moffitt
- START (Grand Rapids)
- START U.S. (San Antonio)
- Sylvester Cancer Center
- Penn State Univ @ Hershey
- University of New Mexico
- University of West Virginia
- University of West Virginia SMO
- Emory
- CTRC (San Antonio)
- University of Louisville
- Roswell Park Cancer Institute
- Frontier Cancer Center
- Fox Chase
- MSKCC
- Institut du Cancer de Montpellier
- Christie NHS
- Sir Bobby Robson CRTC
- Leeds (St. James) Cancer Centre
- START – Madrid, Spain – 2 sites
- Vall D’Hebron
- Hospital Fuenlabrada
- Erasmus MC
Precision’s Oncology Site Network: Find precisely the right sites for your complex oncology trial
Jump-starting immuno-oncology innovation
After a decade of progress, advances in immuno-oncology have slowed. Now, key scientific drivers and peer-reviewed research point to actionable ideas to reinvigorate innovation.
Customized oncology and immuno-oncology solutions
Discover how our oncology & immuno-oncology therapeutic area expertise can advance your clinical development program
Discover how our oncology & immuno-oncology therapeutic area expertise can advance your clinical development program
Services supporting oncology clinical development
Immune Monitoring
Leverage sophisticated immune monitoring approaches, including flow, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.
Genomics
Find and monitor gene expression signatures, copy number variations, chromosome rearrangements, and other genomic events occurring in patient samples using NGS, NanoString, qPCR, ddPCR, and FISH/ISH.
Biostatistics
Seasoned biostatisticians and statistical programmers deliver insight into every trial phase, from study design to regulatory submissions, all backed by meticulous documentation and data monitoring.
